Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Biotinylation Protocol for Next Generation Studies of Red Blood Cell Survival and Function After Transfusion

NCT06788080 is registered in ClinicalTrials.gov with Vitalant Research Institute as lead sponsor.

NCT NCT06788080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06788080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Biotinylation Protocol for Next Generation Studies of Red Blood Cell Survival and Function After Transfusion
Lead sponsor
Vitalant Research Institute
Phase
Phase 1
Overall status
Completed
Start date
March 7, 2024
Completion date
November 4, 2024
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

measuring red blood cell survival after transfusion